NCT00224705View on ClinicalTrials.gov

The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Hepatitis
Interventions
DEVICE

Molecular Adsorbent Recirculating System (MARS®)

Trial Locations (1)

94800

Hôpital Paul Brousse, Villejuif

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00224705 - The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure | Biotech Hunter | Biotech Hunter